9,996
Views
96
CrossRef citations to date
0
Altmetric
Systematic Review

Anticancer Activity of Metformin: A Systematic Review of the Literature

ORCID Icon &
Article: FSO410 | Received 30 Apr 2019, Accepted 21 Jun 2019, Published online: 22 Aug 2019

References

  • AljofanM , DingH. High glucose increases expression of cyclooxygenase-2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells. J. Cell Physiol.222(3), 669–675 (2010).
  • DingH , AljofanM , TriggleCR. Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells. J. Cell Physiol.212(3), 682–689 (2007).
  • ReinehrT , KiessW , KapellenT , AndlerW. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics114(6), 1569–1573 (2004).
  • GiovannucciE , HarlanDM , ArcherMCet al.Diabetes and cancer: a consensus report. Diabetes Care33(7), 1674–1685 (2010).
  • WexlerDJ. Initial management of blood glucose in adults with type 2 diabetes mellitus. NathanMD ( Ed.). UpToDate (2019).
  • CrowleyMJ , DiamantidisCJ , McDuffieJRet al.Metformin use in patients with historical contraindications or precautions. Department of Veterans Affairs (US), DC, USA (2016). www.ncbi.nlm.nih.gov/books/NBK409374/
  • RenaG , HardieDG , PearsonER. The mechanisms of action of metformin. Diabetologia60(9), 1577–1585 (2017).
  • HardieDG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev.25(18), 1895–1908 (2011).
  • DigitalN. Increase in prescriptions for diabetes exceeds rise in overall prescribing (2017). www.digital.nhs.uk
  • SharmaM , NazarethI , PetersenI. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open2016(6), 10–12; e010210 (2015).
  • WangT , McNeillAM , ChenY , SenderakM , ShankarRR. Metformin prescription patterns among US adolescents aged 10–19 years: 2009–2013. J. Clin. Pharm. Ther.41, 229–236 (2016).
  • El-ArabeyAA. Update on off label use of metformin for obesity. Prim. Care Diabetes12(3), 284–285 (2018).
  • ChaeYK , AryaA , MalecekMKet al.Repurposing metformin for cancer treatment: current clinical studies. Oncotarget7(26), 40767–40780 (2016).
  • LiberatiA , AltmanDG , TetzlaffJet al.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann. Intern. Med151(4), W65–W94 (2009).
  • AromatarisE, MunnZ ( Eds). Chapter 1: JBI Systematic Reviews. In: Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute (2017).
  • ZakikhaniM , DowlingR , FantusIG , SonenbergN , PollakM. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res.66(21), 10269–10273 (2006).
  • DengXS , WangS , DengAet al.Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers. Cell Cycle11(2), 367–376 (2012).
  • LiuM , ZhangZ , WangH , ChenX , JinC. Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2. Int. J. Biol. Sci.15(3), 617–627 (2019).
  • MaL , WeiJ , WanJet al.Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways. J. Exp. Clin. Cancer Res.38(1), 77 (2019).
  • HartPC , ChiyodaT , LiuXet al.SPHK1 is a novel target of metformin in ovarian cancer. Mol. Cancer Res. 4, 870–881 (2019).
  • WangL , LiK , LinXet al.Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 Axis. Cancer Lett. 450, 22–31 (2019).
  • LuCC , ChiangJH , TsaiFJet al.Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling. Int. J. Oncol.54(4), 1271–1281 (2019).
  • TsengHW , LiSC , TsaiKW. Metformin treatment suppresses melanoma cell growth and motility through modulation of microRNA expression. Cancers (Basel)11(2), 11–12 (2019).
  • HanawaS , MitsuhashiA , ShozuM. Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer. PLoS ONE13(2), e0192759 (2018).
  • WuL , ZhouB , Oshiro-RapleyNet al.An ancient, unified mechanism for metformin growth inhibition in C. elegans and cancer. Cell167(7), 1705–1718; e1713 (2016).
  • ZordokyBN , BarkD , SoltysCL , SungMM , DyckJR. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention. Biochim. Biophys. Acta1840(6), 1943–1957 (2014).
  • ChenK , QianW , JiangZet al.Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Mol. Cancer16(1), 131 (2017).
  • EvansJM , DonnellyLA , Emslie-SmithAM , AlessiDR , MorrisAD. Metformin and reduced risk of cancer in diabetic patients. BMJ330(7503), 1304–1305 (2005).
  • PauleS , AljofanM , SimonC , RombautsLJ , NieG. Cleavage of endometrial alpha-integrins into their functional forms is mediated by proprotein convertase 5/6. Hum. Reprod.27(9), 2766–2774 (2012).
  • StevenC , PlaxeAJM. Overview of endometrial carcinomaGoffD, DizonDS, VoraSR, FalkSJ ( Eds). USA (2019).
  • ShawRJ , LamiaKA , VasquezDet al.The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science310(5754), 1642–1646 (2005).
  • KahnBB , AlquierT , CarlingD , HardieDG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab.1(1), 15–25 (2005).
  • BikasA , JensenK , PatelAet al.Glucose-deprivation increases thyroid cancer cells sensitivity to metformin. Endocr. Relat. Cancer22(6), 919–932 (2015).
  • CairnsRA , HarrisIS , MakTW. Regulation of cancer cell metabolism. Nat. Rev. Cancer11(2), 85–95 (2011).
  • ChanNN. Improved endothelial function with metformin in type 2 diabetes mellitus. J. Am. Coll. Cardiol.38(7), 2131–2132 (2001).
  • McCullochDavid K. Metformin in the treatment of adults with type 2 diabetes mellitus. FunnellM ( Ed.). Sourcebook, Inc., IL, USA, Topic 1809 Version 40.0 (2018).
  • PyneNJ , TonelliF , LimKG , LongJS , EdwardsJ , PyneS. Sphingosine 1-phosphate signalling in cancer. Biochem. Soc. Trans.40(1), 94–100 (2012).
  • ShidaD , TakabeK , KapitonovD , MilstienS , SpiegelS. Targeting SphK1 as a new strategy against cancer. Curr. Drug Targets9(8), 662–673 (2008).
  • CuvillierO , PirianovG , KleuserBet al.Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature381(6585), 800–803 (1996).
  • WangWJ , ChenD , JiangMZet al.Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins. J. Dig. Dis.19(2), 74–83 (2018).
  • AljofanM , GaipovA. Metformin: a stroke of luck. Electron. J. Gen. Med.16(3), em143 (2019).
  • BridgemanSC , EllisonGC , MeltonPE , NewsholmeP , MamotteCDS. Epigenetic effects of metformin: From molecular mechanisms to clinical implications. Diabetes Obes. Metab.20(7), 1553–1562 (2018).
  • MallikR , ChowdhuryTA. Metformin in cancer. Diabetes Res. Clin. Pract.143, 409–419 (2018).
  • AmaralI , SilvaC , Correia-BrancoA , MartelF. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells. Biomed. Pharmacother.102, 94–101 (2018).
  • TanM , WuA , LiaoNet al.Inhibiting ROS-TFE3-dependent autophagy enhances the therapeutic response to metformin in breast cancer. Free Radic. Res.52(8), 872–886 (2018).
  • DevadasuVR , AlshammariTM , AljofanM. Current advances in the utilization of nanotechnology for the diagnosis and treatment of diabetes. Int. J. Diabetes Dev. C38(1), 11–19 (2018).
  • HeY , TanX , HuHet al.Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway. Oncol. Lett.15(3), 2939–2945 (2018).
  • LiZ , WangL , LuoNet al.Metformin inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the phosphorylation of Akt. Oncol. Lett.15(5), 7948–7954 (2018).
  • ChengK , HaoM. Metformin inhibits TGF-beta1-induced epithelial-to-mesenchymal transition via PKM2 relative-mTOR/p70s6k signaling pathway in cervical carcinoma cells. Int. J. Mol. Sci.17(12), 8–12 (2016).
  • DosSantos Guimaraes I , Ladislau-MagesckyT , TessarolloNGet al.Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines. Pharmacol. Rep.70(3), 409–417 (2018).
  • MaderaD , Vitale-CrossL , MartinDet al.Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3. Cancer Prev. Res.8(3), 197–207 (2015).
  • XiongY , LuQJ , ZhaoJ , WuGY. Metformin inhibits growth of hepatocellular carcinoma cells by inducing apoptosis via mitochondrion-mediated pathway. Asian Pac. J. Cancer Prev.13(7), 3275–3279 (2012).
  • TomicT , BottonT , CerezoMet al.Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis.2, e199 (2011).
  • WillowsR , NavaratnamN , LimaA , ReadJ , CarlingD. Effect of different gamma-subunit isoforms on the regulation of AMPK. Biochem. J.474(10), 1741–1754 (2017).
  • SongIS , KimHK , LeeSRet al.Mitochondrial modulation decreases the bortezomib-resistance in multiple myeloma cells. Int. J. Cancer133(6), 1357–1367 (2013).
  • WeiM , MaoS , LuGet al.Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal. BMC Cancer18(1), 434 (2018).
  • PengM , DarkoKO , TaoTet al.Combination of metformin with chemotherapeutic drugs via different molecular mechanisms. Cancer Treat. Rev.54, 24–33 (2017).
  • FriedenreichCM , NeilsonHK , WangQet al.Effects of exercise dose on endogenous estrogens in postmenopausal women: a randomized trial. Endocr. Relat. Cancer22(5), 863–876 (2015).
  • WangJ , LiG , WangYet al.Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1alpha/VEGF secretion axis. Oncotarget6(42), 44579–44592 (2015).
  • ZhenS , LuJ , ChenW , ZhaoL , LiX. Synergistic antitumor effect on bladder cancer by rational combination of programmed cell death 1 blockade and CRISPR-Cas9-mediated long non-coding RNA urothelial carcinoma associated 1 knockout. Hum. Gene Ther.29(12), 1352–1363 (2018).
  • SunS , GongF , LiuP , MiaoQ. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway. Gene664, 50–57 (2018).
  • LibertiMV , LocasaleJW. The Warburg effect: how does it benefit cancer cells?Trends Biochem. Sci.41(3), 211–218 (2016).
  • LocasaleJW , CantleyLC. Metabolic flux and the regulation of mammalian cell growth. Cell Metab.14(4), 443–451 (2011).
  • MenendezJA , Oliveras-FerrarosC , CufiSet al.Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle11(15), 2782–2792 (2012).
  • SaitoS , FurunoA , SakuraiJet al.Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation. Cancer Res.69(10), 4225–4234 (2009).
  • YangJ , WeiJ , WuYet al.Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer. Oncogenesis4, e158 (2015).
  • LeungDTH , ChuS. Measurement of oxidative stress: mitochondrial function using the seahorse system. Methods Mol. Biol.1710, 285–293 (2018).
  • AljofanM. Hendra and Nipah infection: emerging paramyxoviruses. Virus Res.177(2), 119–126 (2013).
  • AljofanM , LoMK , RotaPA , MichalskiWP , MungallBA. Off label antiviral therapeutics for henipaviruses: new light through old windows. J. Antivir. Antiretrovir.2(1), 1–10 (2010).
  • RuizA , MatuteC , AlberdiE. Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes. Cell Death Dis.1, e54 (2010).
  • KritsiligkouP , RandJD , WeidsAJ , WangX , KershawCJ , GrantCM. Endoplasmic reticulum (ER) stress-induced reactive oxygen species (ROS) are detrimental for the fitness of a thioredoxin reductase mutant. J. Biol. Chem.293(31), 11984–11995 (2018).
  • ValaeeS , YaghoobiMM , ShamsaraM. Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner. PLoS ONE12(3), e0174486 (2017).
  • SuT , LiaoB , DongYet al.Effect of metformin on colorectal carcinoma in type 2 diabetes mellitus patients: a Markov model analysis. Zhonghua Wei Chang Wai Ke Za Zhi20(6), 689–693 (2017).
  • GallagherEJet al.Inhibiting PI3K reduces mammary tumor growth andinduces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia. Oncogene31(27), 3213–3222 (2012).